Funds and ETFs Wakamoto Pharmaceutical Co.,Ltd.

Equities

4512

JP3991200001

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 28/06/2024 BST 5-day change 1st Jan Change
259 JPY -0.77% Intraday chart for Wakamoto Pharmaceutical Co.,Ltd. +2.37% +21.60%

ETFs positioned on Wakamoto Pharmaceutical Co.,Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.01% 14 M€ +14.19%
0.00% 17 M€ +18.02% -
0.00% 138,841 M€ +19.96%
0.00% 19,753 M€ +18.95% -
WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.
More about the company
  1. Stock Market
  2. Equities
  3. 4512 Stock
  4. Funds and ETFs Wakamoto Pharmaceutical Co.,Ltd.